GT Biopharma, Inc. Financial Ratios — GTBP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	-196.81	- -	- -	- -	-124.15	-79.1	- -	- -
Return on Assets (%)	-2,356.69	-2,913.24	-268.63	-4,538.94	-4,550.11	24,729.11	-113.35	-185.29	-299.65	-934.32	-306.7	-85.41	-49.26	-143.53	-459.62
Return on Capital (%)	- -	- -	- -	- -	- -	-68.97	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-84.62	72.51	38.59	6.56	100	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-15,019.23	-1,026.61	-214.95	-3,891.8	-33,055.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-15,107.69	-1,027.49	-215.49	-3,927.87	-33,062.96	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	1,655.56	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-14,230.77	-1,538.3	-136.14	-38,532.79	-79,485.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-14,230.77	-1,511.99	-136.14	-38,506.56	-79,374.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-14,230.77	-1,511.99	-136.14	-38,506.56	-79,374.07	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.32
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	-196.81	- -	- -	- -	-124.15	-79.1	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	2	3	3	10	12	- -	11	13	26	- -	- -	- -	- -	- -
ST Debt	2	2	2	3	9	12	- -	11	13	26	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.53	-0.54	-3.27	-1.41	-1.09	-1.32	- -	-0.5	-1.17	-3.89	- -	-0.01	- -	- -	- -
Net Debt/EBITDA	-0.5	-0.5	-3.22	-1.05	-1.09	-1.32	- -	-0.5	-1.15	-3.11	0.16	0.27	0.08	0.28	0.55
Total Debt/EBIT	-0.52	-0.54	-3.26	-1.4	-1.09	-1.32	- -	-0.5	-1.17	-3.89	- -	-0.01	- -	- -	- -
Net Debt/EBIT	-0.5	-0.5	-3.21	-1.05	-1.09	-1.32	- -	-0.5	-1.15	-3.11	0.16	0.27	0.08	0.28	0.55
EBITDA to Interest Expense	-7.02	-2.12	-0.66	-0.46	-0.52	-1.43	-15.76	-2.36	-5.38	-2.04	-80.1	-2,657.12	-63.74	- -	-97.81
EBITDA-CapEx/Interest Expense	-7.02	-2.13	-0.66	-0.46	-0.52	-1.43	-15.76	-2.37	-5.38	-2.04	-80.1	-2,657.12	-63.74	- -	-97.81
EBIT to Interest Expense	-7.06	-2.13	-0.66	-0.47	-0.52	-1.43	-15.76	-2.36	-5.38	-2.04	-80.1	-2,657.12	-63.74	- -	-97.81
Interest Expense	1	2	1	5	17	7	9	9	2	3	1	- -	- -	- -	- -
Common Equity/Total Assets	-3,956.59	-2,765.04	-4,206.8	-3,311.71	-93,338.89	-75,032	99.01	45.42	-4,834.34	-516.99	68.11	70.11	52.98	-39.48	71.38
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.55	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-2.59	-2.42	-1.75	- -	- -	- -	- -	- -	- -	0.54	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	65.99	71.4	1,322.22	- -	- -	- -	- -	- -	- -	0.38	- -	- -	- -
Total Debt/Equity (%)	-40.4	-29.67	-40.86	-11.36	-19.27	-65.59	0.01	95.02	-69.18	-89.47	0.14	1.48	0.78	- -	- -
Total Debt/Capital (%)	-67.8	-42.19	-69.09	-12.81	-23.88	-190.65	0.01	48.72	-224.43	-849.76	0.14	1.46	0.77	- -	- -
Total Debt/Total Assets (%)	1,597.67	831.86	1,760.54	378.27	18,050	49,652	0.01	42.54	3,373.23	465.18	0.1	1.04	0.41	- -	- -
Net Debt to Equity	-38.6	-27.73	-40.18	-8.47	-19.18	-65.49	-0.22	94.49	-68.41	-71.47	-40.79	-48.34	-14.43	236.59	-117.69
Net Debt/Capital (%)	-62.87	-38.37	-67.17	-9.25	-23.73	-189.8	-0.22	48.58	-220.9	-250.56	-68.89	-90.96	-16.72	70.29	665.14
EBITDA	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
EBITDA-CapEx	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
Operating Income (Loss)	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.02	0.02	0.01	0.03	- -	- -	0.22	- -	- -	0.15	3.12	3.34	2.11	0.67	2.94
Current Ratio	0.02	0.03	0.02	0.03	- -	- -	0.22	0.01	0.01	0.16	3.14	3.35	2.12	0.72	3.5
Quick Ratio	0.02	0.02	0.01	0.03	- -	- -	0.22	- -	- -	0.15	3.12	3.34	2.11	0.67	2.94
CFO/Avg Current Liab	-0.18	-0.17	-0.07	-0.1	-0.12	-0.06	-0.5	-1.28	-0.22	-0.27	-0.69	-2	-1.53	-2.06	-3.14
Common Equity/Total Assets	-3,956.59	-2,765.04	-4,206.8	-3,311.71	-93,338.89	-75,032	99.01	45.42	-4,834.34	-516.99	68.11	70.11	52.98	-39.48	71.38
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.55	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	-2.59	-2.42	-1.75	- -	- -	- -	- -	- -	- -	0.54	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	65.99	71.4	1,322.22	- -	- -	- -	- -	- -	- -	0.38	- -	- -	- -
Total Debt/Equity (%)	-40.4	-29.67	-40.86	-11.36	-19.27	-65.59	0.01	95.02	-69.18	-89.47	0.14	1.48	0.78	- -	- -
Total Debt/Capital (%)	-67.8	-42.19	-69.09	-12.81	-23.88	-190.65	0.01	48.72	-224.43	-849.76	0.14	1.46	0.77	- -	- -
Total Debt/Total Assets (%)	1,597.67	831.86	1,760.54	378.27	18,050	49,652	0.01	42.54	3,373.23	465.18	0.1	1.04	0.41	- -	- -
CFO/Total Liabilities	-18.41	-15.04	-6.82	-5.74	-9.2	-10.19	-202.69	-76.11	-18.57	-20.69	-152.12	-304.22	-133.45	-218.64	-556.88
CFO/CapEx	- -	-493.5	- -	-291.5	-4,657	- -	-1,357.5	-296.58	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-1,311.54	-710.09	-1,080.11	-226.04	-5,137.92	-9,123.89	-150.92	-6,008.7	-2,155.78	-141.45	109.45	27.13	-46.34	-224.34	0.46

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	18.4	3.05	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	19.84	119.67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	8	2.65	4.48	2.71	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	45.62	137.85	81.56	134.47	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.08	0.17	0.23	0.02	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	4,352.62	2,179.65	1,587.49	16,449.33	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	-4,307	-2,041.8	-1,486.09	-16,195.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-45.62	-137.85	-61.72	-14.8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	75	5,576	823	141	940	2,445	725	264	170	501
- Cash & Cash Equivalents	- -	- -	- -	1	- -	- -	1	- -	- -	5	9	6	1	4	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	2	3	3	10	12	- -	11	13	26	- -	- -	- -	- -	- -
Enterprise Value	2	2	2	2	10	87	5,575	834	154	961	2,413	708	250	166	494
Total Capital	-3	-4	-4	-26	-41	-7	252	22	-6	-3	22	12	8	-2	6
Total Debt/Capital (%)	-67.8	-42.19	-69.09	-12.81	-23.88	-190.65	0.01	48.72	-224.43	-849.76	0.14	1.46	0.77	- -	- -
Total Debt / EV	1.05	1.13	1.08	1.44	1.02	0.14	- -	0.01	0.09	0.03	- -	- -	- -	- -	- -
EV/Sales	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	2.51	3.18	0.69	0.77	18.83	1,757.55	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	2.5	3.18	0.69	0.77	18.83	1,755.33	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	75	1,866	816	7	13,434	2,147	713	258	145	108
Diluted Enterprise Value	2	2	2	2	10	87	1,865	827	20	13,454	2,138	707	257	141	101
EV per Share	281,714.29	128,461.54	171,071.43	155,866.67	635,600	426,986.18	56,730.25	8,394	1,128.95	5,525.99	2,257.61	649.28	181.17	74.48	19.36
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
TTM Operating Income	-4	-4	-1	-2	-9	-9	-136	-22	-11	-7	-58	-21	-14	-14	-12
TTM Cash Flow to Firm	- -	1	1	3	12	5	3	-2	-2	-4	-15	-15	-9	-13	-13
TTM Free Cash Flow to Firm	- -	1	1	3	12	5	3	-2	-2	-4	-15	-15	-9	-13	-13

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	-38.8	-343.81	-76.72	-1.87	-1,849.85	-137.57	-46.84	-29.12	-11.21	-8.38
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	2	2	2	2	10	87	5,575	834	154	961	2,413	708	250	166	494
Low Price	- -	- -	- -	- -	- -	309,090.5	38,636.25	7,395	828.75	988.25	2,220	656.75	134.75	43	13.5
EV/Sales	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	7.67	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	18.92	-28.9	-9.3	-0.65	-199.74	-108.12	-93.18	-54	-12.49	-8.51
Price/Earnings High	- -	- -	- -	- -	- -	76.66	-231.12	-28.35	-2.11	-862.17	-239.43	-144.12	-146.36	-38.42	-18.51
Price/Earnings Low	- -	- -	- -	- -	- -	6.46	-8.81	-2.81	-0.14	-86.79	-35.91	-33.74	-23.9	-6.2	-2.6
Price/Book Value	- -	- -	- -	- -	- -	-3.99	22.14	71.34	-7.38	-32.13	111.59	61.75	35.32	-101.96	86.63
Price/Book Value Average	- -	- -	- -	- -	- -	-9.85	49.44	210.54	-26.93	-13.52	326.01	168.6	56.22	-115.85	195.23
Price/Book Value High	- -	- -	- -	- -	- -	-39.92	395.43	642.08	-87.94	-58.35	721.94	260.76	152.38	-356.34	424.76
Price/Book Value Low	- -	- -	- -	- -	- -	-3.36	15.08	63.66	-5.92	-5.87	108.29	61.05	24.89	-57.5	59.58
Price/Tangible Book Value	- -	- -	- -	- -	- -	-3.99	-2,902.47	-59.97	-7.38	-32.13	111.59	61.75	35.32	-101.96	86.63
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	-9.85	-6,481.85	-176.98	-26.93	-13.52	326.01	168.6	56.22	-115.85	195.23
Price/Tangible Book Value High	- -	- -	- -	- -	- -	-39.92	-51,843.23	-539.72	-87.94	-58.35	721.94	260.76	152.38	-356.34	424.76
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	-3.36	-1,976.48	-53.51	-5.92	-5.87	108.29	61.05	24.89	-57.5	59.58
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	-38.8	-343.56	-76.46	-1.87	-1,849.85	-137.57	-46.84	-29.12	-11.21	-8.38
Price/Cash Flow Average	- -	- -	- -	- -	- -	-95.78	-767.24	-225.66	-6.83	-778.29	-401.92	-127.89	-46.35	-12.74	-18.89
Price/Cash Flow High	- -	- -	- -	- -	- -	-387.96	-6,136.58	-688.17	-22.31	-3,359.39	-890.03	-197.79	-125.61	-39.19	-41.09
Price/Cash Flow Low	- -	- -	- -	- -	- -	-32.67	-233.95	-68.23	-1.5	-338.16	-133.51	-46.31	-20.52	-6.32	-5.76
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	-95.78	-767.81	-226.42	-6.83	-778.29	-401.92	-127.89	-46.35	-12.74	-18.89
Price/Free Cash Flow High	- -	- -	- -	- -	- -	-387.96	-6,141.1	-690.5	-22.31	-3,359.39	-890.03	-197.79	-125.61	-39.19	-41.09
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	-32.67	-234.12	-68.46	-1.5	-338.16	-133.51	-46.31	-20.52	-6.32	-5.76
EV/Sales Average	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	75.85	4.88	6.51	38.33	353.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-0.5	-0.48	-3.03	-0.98	-1.07	-21.03	-91.84	-113.22	-46.17	-61.57	-124.03	-92.8	-30.88	-13.2	-90.39
EV/EBITDA High	-0.5	-0.48	-3.03	-0.98	-1.07	-81.19	-734.61	-344.28	-148.15	-255.54	-274.85	-143.67	-83.82	-41.18	-197.3
EV/EBITDA Low	-0.5	-0.48	-3.03	-0.98	-1.07	-8.03	-28	-34.58	-11.05	-28.5	-41.1	-33.44	-13.63	-6.41	-27.2
EV/EBIT Average	-0.5	-0.48	-3.02	-0.98	-1.07	-21.02	-91.84	-113.19	-46.15	-61.57	-124.03	-92.8	-30.88	-13.2	-90.39
EV/EBIT High	-0.5	-0.48	-3.02	-0.98	-1.07	-81.18	-734.6	-344.17	-148.09	-255.54	-274.85	-143.67	-83.82	-41.18	-197.3
EV/EBIT Low	-0.5	-0.48	-3.02	-0.98	-1.07	-8.03	-28	-34.56	-11.05	-28.5	-41.1	-33.44	-13.63	-6.41	-27.2
Last Price	- -	- -	- -	- -	- -	367,045	56,737.5	8,287.5	1,032.75	5,406	2,287.5	664.25	191.25	76.25	19.63
High Price	- -	- -	- -	- -	- -	3,670,451	1,013,430.75	74,587.5	12,303.75	9,817.5	14,799.75	2,805	825	266.5	96.25
Enterprise Value Average	2	2	2	2	10	197	12,451	2,440	529	416	7,134	1,973	419	190	1,123
Enterprise Value High	2	2	2	2	10	761	99,590	7,418	1,697	1,728	15,808	3,054	1,138	591	2,451
Enterprise Value Low	2	2	2	2	10	75	3,796	745	127	193	2,364	711	185	92	338

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	26
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	1	2	6
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	1	1	1	2	6
Revenue per Share	3,714.29	26,307.69	26,285.71	4,066.67	1,800	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-557,857.14	-270,076.92	-56,500	-158,266.67	-595,000	-45,946.08	-4,123.11	-218.73	-1,726.15	-2.72	-61.28	-19.81	-10.07	-7.57	-2.25
Operating Income per Share	-561,142.86	-270,307.69	-56,642.86	-159,733.33	-595,133.33	-45,950.98	-4,123.18	-218.8	-1,726.75	-2.72	-61.28	-19.81	-10.07	-7.57	-2.25
Basic EPS, GAAP	-528,571.43	-397,769.23	-35,785.71	-1,565,933.33	-1,428,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.2
Basic EPS from Cont Ops	-528,571.43	-404,692.31	-35,785.71	-1,567,000	-1,430,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.14
Diluted EPS, GAAP	-528,571.43	-397,769.23	-35,785.71	-1,565,933.33	-1,428,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.2
Diluted EPS from Cont Ops	-528,571.43	-404,692.31	-35,785.71	-1,567,000	-1,430,733.33	47,882.35	-4,384.79	-2,631.06	-5,824.72	-11.39	-61.81	-19.46	-5.64	-6.94	-5.14
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.04
Cash Flow per Share	-137,571.43	-75,923.08	-31,571.43	-116,600	-310,466.67	-9,460.78	-165.15	-108.38	-551.47	-2.92	-16.63	-14.18	-6.57	-6.8	-2.34
Free Cash Flow per Basic Share	-137,571.43	-76,076.92	-31,571.43	-117,000	-310,533.33	-9,460.78	-165.27	-108.75	-551.47	-2.92	-16.63	-14.18	-6.57	-6.8	-2.34
Cash & Equivalents per Share	13,142.86	9,461.54	3,071.43	57,000	3,133.33	93.14	5.86	0.6	0.2	30.45	29.92	15.13	10.12	1.77	0.27
Book Value per Share	-729,142.86	-480,692.31	-441,714.29	-1,960,533.33	-3,360,200	-91,950.98	2,562.87	116.17	-139.91	-168.26	20.5	10.76	5.41	-0.75	0.23
Tangible Book Value per Share	-732,714.29	-482,538.46	-443,285.71	-1,960,533.33	-3,360,200	-91,950.98	-19.55	-138.2	-139.91	-168.26	20.5	10.76	5.41	-0.75	0.23

GT Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)